Pig endogenous retrovirus - A threat to clinical xenotransplantation?

APMIS

Volumn 108, Issue 4, 2000, Pages 241-250

  Fiane, Arnt E ^a,c   Mollnes, Tom E ^a,b   Degré, Miklos ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clinical xenotransplantation; Pig endogenous retrovirus; Retrovirus transmission; Risk

Indexed keywords

DNA; RNA;

HUMAN; INFECTION RISK; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SWINE; TRANSGENIC ANIMAL; VIRUS GENOME; VIRUS TRANSMISSION; XENOTRANSPLANTATION; ZOONOSIS;

EID: 0034070499     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-51.x     Document Type: Review

References (40)

1. 1. Ewans RW, Orians CE, Ascher NL. The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA 1992;267:239-46.
2. 2. Pierce GA, Kauffman HM, Ellison MD, Edwards EB, Klein DH, Wolf JS, et al. UNOS scientific registry: present and future. Transplant Proc 1996;28:317-40.
3. 3. Borie DC, Cramer DV, Phan-Thanh L, Vaillant JC, Bequet JL, Makowka L, et al. Microbial hazards related to xenotransplantation of porcine organs into man. Infect Control Hosp Epidemiol 1998;19:355-65.
4. 4. Coffin JM. Retroviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology, 3rd edition. Philadelphia, New York: Lippincott-Raven Publishers, 1996:1767-847.
5. 5. Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998;72:9986-91.
6. 6. Akiyoshi DE, Denaro M, Zhu H, Greenstein JL, Banerjee P, Foshman JA. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998;72:4503-7.
7. 7. Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss R. Two sets of human-tropic pig retroviruses. Nature 1997;389:681-2.
8. 8. Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998;72:3082-7.
9. 9. Martin U, Klessig V, Blusch JH, Haverich A, van der Helm K, Herden T, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998;352:692-4.
10. 10. Stoye JP. Xenotransplantation - proviruses pose potential problems. Nature 1997;386:126-7.
11. 11. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-6.
12. 12. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995;69:1903-6.
13. 13. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 1994;91:6245-9.
14. 14. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75:295-305.
15. 15. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67:6025-32.
16. 16. Holberg-Petersen M, Bukholm G, Rollag H, Degré M. Infection with human cytomegalovirus enhances bacterial invasiveness in permissive and semipermissive cells. APMIS 1994;102:703-10.
17. 17. Hagemeier C, Walker SM, Sissons PJG, Sinclair JH. The 72 IE1 and 80K IE2 proteins of human cytomegalovirus independently transactivate the c-fos, c-myc and hsp70 promoters via basal promoter elements. J Gen Virol 1992;73:2385-93.
18. 18. Chapman LE, Heneine W, Switzer W, Sandstrom P, Folks TM. Xenotransplantation: the potential for xenogeneic infections. Transplant Proc 1999;31:909-10.
19. 19. Stoye JP, Le Tissier P, Takeuchi Y, Patience C, Weiss RA. Endogenous retroviruses: a potential problem for xenotransplantation? Ann NY Acad Sci 1998;862:67-74.
20. 20. Weiss RA. Xenografts and retroviruses. Science 1999;285:1221-2.
21. 21. Brown J, Matthews AL, Sandstrom PA, Chapman LE. Xenotransplantation and the risk of retroviral zoonosis. Trends Microbiol 1998;6:411-5.
22. 22. Stoye J. No clear answers on safety of pigs as tissue donor source. Lancet 1998;352:666-7.
23. 23. Switzer WM, Shanmugam V, Chapman L, Heneine W. Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and non-human recipients of pig xenografts. Transplantation 1999;68:183-8.
24. 24. Matthews AL, Brown J, Switzer W, Folks TM, Heneine W, Sandstrom PA. Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus. Transplantation 1999;67:939-43.
25. 25. Hoopes CW, Platt JL. Screening by tRNA primer extension analysis of porcine kidney mRNA libraries defines a novel endogenous porcine retroviral long terminal repeat. Transplantation 1999;67:1391-5.
26. 26. Martignat L, Sai P, Jestin A. Detection of porcine endogenous retrovirus: possible involvement in pig islet xenotransplantation. Diabetes Metab 1998;24:434-41.
27. 27. Silver J, Maudru T, Fujita K, Repaske R. An Rt-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucleic Acid Res 1993;21:3593-4.
28. 28. Heneine W, Yamamoto S, Switzer WM, Soira TJ, Folks TM. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type I. J Infect Dis 1995;171:1210-6.
29. 29. Schüpbach J. Xenotransplantation and viruses -the model of retroviruses. Schweiz Med Wochenschr 1998;128:935-43.
30. 30. Lovatt A, Black J, Galbraith D, Doherty I, Moran MW, Shepherd AJ, et al. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods 1999;82:185-200.
31. 31. World Health Organisation. Xenotransplantation: Guidance on infectious disease prevention and management. WHO/EMC/ZOO/98.1.
32. 32. Martin U, Steinhoff G, Kiessig V, Chikobava M, Anssar M, Morschheuser T, et al. Porcine retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transplant Int 1998;11:247-51.
33. 33. Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998;352:695-9.
34. 34. Pitkin Z, Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999;23:829-33.
35. 35. Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporal connection to pig kidneys. Lancet 1998;352:699-701.
36. 36. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, et al. Search for cross-species transmission of porcine retrovirus in patients treated with living pig tissue. Science 1999;285:1236-41.
37. 37. Birmingham K. FDA subcommittee finds no evidence of PERV transmission. Nat Med 1999;5:855.
38. 38. Hopkins J. Study gives reassurance on safety of xenotransplantation. BMJ 1999;319:533.
39. 39. Lower R. The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol 1999;7:350-6.
40. 40. Novartis satelite symposium. Meeting the challenges through partnership in transplantation. XVIIth World Congress in Transplantation. Canada, July 12th, 1998. Montreal: The Transplantation Society, 1998.